ArticleOncology letters2018

Long-lasting memory of cellular immunity in a chronic myeloid leukemia patient maintains molecular response 5 after cessation of dasatinib.

Tatsuro Jo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.